Viewing nowCombinationEmpagliflozin 2L-Proline/Metformin 12.5/500 mg Tablet
Empagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 202502977 · Approved 2025.11.18
Improvement of glycemic control in patients with type 2 diabetes
This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It is particularly suitable for patients whose blood sugar is not adequately controlled, and it should be used cautiously in patients with cardiovascular disease. It is important to reference expert clinical trial information before starting this medication. This medication effectively helps with blood sugar management and contributes to the prevention of diabetes-related complications.
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) plus the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the total daily dose of empagliflozin may be increased to 25 mg. Patients switching to this drug from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This drug should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this drug, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in this case. No dose adjustment is necessary in patients with mild renal impairment. Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this drug immediately. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.
This medication can cause a rare side effect called severe lactic acidosis, so it should be used with caution, especially in patients with impaired kidney function, heart disease, or liver disease. When used in combination with other diabetes medications, hypoglycemic symptoms may occur, so blood sugar levels should be closely monitored. This medication should not be used in patients with moderate or severe renal impairment or in cases where acute kidney injury is suspected. It may be temporarily discontinued when a patient is in an unstable state, such as during acute infections, dehydration, severe trauma, or around surgery. Pregnant women or those who may become pregnant, and nursing mothers are advised not to take this medication. Elderly patients should have their kidney function regularly monitored due to a higher risk of renal impairment. This medication may increase the risk of urinary tract infections and genital infections, so medical consultation should be sought immediately in case of infection symptoms. Patients with dehydration or low blood pressure should be particularly cautious, as this medication may cause fluid loss; it may be temporarily discontinued if necessary. Vitamin B12 deficiency may occur, so those on long-term treatment should regularly check their vitamin B12 levels. It is important to avoid alcohol while taking this medication. If sudden fatigue, muscle pain, or breathing difficulties occur, visit the hospital immediately. Additionally, as this medication can affect blood sugar control, blood sugar levels should be checked regularly, and dosages should be adjusted as instructed by a healthcare provider. Before surgery or tests that involve contrast agents, this medication should be discontinued and resumed only after kidney function has returned to normal. During treatment with this medication, symptoms of hypoglycemia, lactic acidosis, and ketoacidosis should be carefully monitored, and any abnormal symptoms should be reported to healthcare professionals immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and should be kept at room temperature between 1 to 30 degrees Celsius. Proper storage maintains the medication's effectiveness for a longer period.
Pale purple oval film-coated tablet
30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.9mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.56mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.